We are live on ! Find out more
OMIC

Singular Genomics Systems, Inc. Common Stock
OMIC

Delisted

OMIC was delisted on the 20th of February, 2025.

Back to rankings

52 hedge funds and large institutions have $757M invested in Singular Genomics Systems, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+52
Holders Change %
–
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
52
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$235M
2
PA
Perceptive Advisors
New York
+$79.6M
3
CC
Casdin Capital
New York
+$69.6M
4
Coatue Management
Coatue Management
New York
+$54.8M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$54.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NAM
26
Nexpoint Asset Management
Texas
$1.08M +$1.01M +1,305 New
MWNA
27
Marshall Wace North America
New York
$1.07M +$1M +1,296 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$1.05M +$986K +1,272 New
PCM
29
Pinz Capital Management
New York
$1M +$940K +1,213 New
CCM
30
CAAS Capital Management
New York
$824K +$775K +1,000 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$801K +$753K +971 New
Fidelity International
32
Fidelity International
Bermuda
$711K +$669K +863 New
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$594K +$559K +721 New
Federated Hermes
34
Federated Hermes
Pennsylvania
$550K +$517K +667 New
ECM
35
ExodusPoint Capital Management
New York
$437K +$411K +530 New
Two Sigma Investments
36
Two Sigma Investments
New York
$413K +$388K +501 New
LCM
37
Legato Capital Management
California
$327K +$308K +397 New
GCM
38
Ghisallo Capital Management
Massachusetts
$275K +$258K +333 New
MS
39
Maven Securities
Jersey
$275K +$258K +333 New
ZP
40
Zimmer Partners
New York
$275K +$258K +333 New
Wellington Management Group
41
Wellington Management Group
Massachusetts
$264K +$249K +321 New
Squarepoint
42
Squarepoint
New York
$258K +$243K +313 New
Tudor Investment Corp
43
Tudor Investment Corp
Connecticut
$244K +$229K +296 New
MUMSS
44
Mitsubishi UFJ Morgan Stanley Securities
Japan
$95K +$89.1K +115 New
Bank of America
45
Bank of America
North Carolina
$48K +$45K +58 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$30K +$27.9K +36 New
PIM
47
Platinum Investment Management
Australia
$27K +$25.6K +33 New
Legal & General Group
48
Legal & General Group
United Kingdom
$14K +$13.2K +17 New
HI
49
Harbour Investments
Wisconsin
$5K +$4.65K +6 New
UBS Group
50
UBS Group
Switzerland
$3K +$2.33K +3 New
1
2
3

OMIC Hedge Fund Activity: Q2 2021 in Review

52 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q2 2021, worth a combined $757M.

Buyers outnumbered sellers: 52 funds opened new OMIC positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $235M.

  • 52 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $757M of Singular Genomics Systems, Inc. Common Stock stock for Q2 2021.
  • 52 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q2 2021 and 0 closed out, a net change of +52 holders.
  • The largest Singular Genomics Systems, Inc. Common Stock buyer in Q2 2021 was Deerfield Management, an estimated $235M added.

Based on aggregated 13F filings for Q2 2021.